Spectrum Pharmaceuticals, Inc. SPPI announced that it has added two new cohorts in the phase II study — ZENITH20. The study is evaluating its pipeline candidate, poziotinib, in non-small cell lung ...

In peer-reviewed research of 51,000 pregnant women, Ben-Gurion University scientists find that if hormone imbalance is ...

Spectrum Pharmaceuticals, Inc. SPPI announced positive data from a phase III study, ADVANCE, evaluating its lead pipeline candidate, Rolontis, for management of chemotherapy-induced neutropenia in ...

The Middle Class Tax Relief and Job Creation Act of 2012 (the same law that allowed incentive auction of TV spectrum) required the General Accounting Office to conduct a study of spectrum efficiency, ...

Europe’s mobile operators could unlock billions in potential infrastructure investment, accelerating 5G standalone (5G SA) ...

The FAA is part of a multi-agency team that has received approval from the Office of Management and Budget (OMB) for approximately $71.5 million in funding to proceed with an effort to study the ...

Shares of Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) saw a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer (NSCLC) study. Specifically, the ...

WASHINGTON, March 12 (Reuters) - The Biden administration on Tuesday released a detailed timeline for studying significant government-owned spectrum with the aim of helping to expand wireless and ...